{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:51:34Z","timestamp":1788443494541,"version":"build-2803163510"},"reference-count":193,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006438","name":"US Department of Health and Human Services Office of the Assistant Secretary for Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ijid.2022.04.004","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T02:02:18Z","timestamp":1649210538000},"page":"187-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Lassa Virus Infection: a Summary for Clinicians"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2579-1104","authenticated-orcid":false,"given":"Vanessa","family":"Raabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneesh K","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared D.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Beitscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Bhadelia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brett-Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore J","family":"Cieslak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared D","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Iwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G","family":"Kortepeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corri","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneesh K","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon","family":"Zachary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0001","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1038\/s41467-018-06741-w","article-title":"Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever","volume":"9","author":"Abreu-Mota","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijid.2022.04.004_bib0002","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijid.2020.11.006","article-title":"Acute kidney injury and mortality in pediatric Lassa fever versus question of access to dialysis","volume":"103","author":"Adetunji","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2022.04.004_bib0003","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.cell.2015.07.020","article-title":"Clinical sequencing uncovers origins and evolution of Lassa virus","volume":"162","author":"Andersen","year":"2015","journal-title":"Cell"},{"issue":"4-5","key":"10.1016\/j.ijid.2022.04.004_bib0004","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0166-3542(90)90009-V","article-title":"Inhibitory effect of selected antiviral compounds on arenavirus replication in vitro","volume":"14","author":"Andrei","year":"1990","journal-title":"Antiviral Res"},{"issue":"9","key":"10.1016\/j.ijid.2022.04.004_bib0005","doi-asserted-by":"crossref","first-page":"e1839","DOI":"10.1371\/journal.pntd.0001839","article-title":"Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation","volume":"6","author":"Asogun","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.ijid.2022.04.004_bib0006","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.idc.2019.08.002","article-title":"Lassa fever: Epidemiology, clinical features, diagnosis, management and prevention","volume":"33","author":"Asogun","year":"2019","journal-title":"Infect Dis Clin North Am"},{"issue":"11","key":"10.1016\/j.ijid.2022.04.004_bib0007","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1128\/JVI.01948-08","article-title":"Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys","volume":"83","author":"Baize","year":"2009","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.ijid.2022.04.004_bib0008","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.micinf.2006.02.002","article-title":"Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages","volume":"8","author":"Baize","year":"2006","journal-title":"Microbes Infect"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0009","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1038\/s41467-020-17994-9","article-title":"Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time","volume":"11","author":"Barnes","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008811","article-title":"Bridging the gap: Using reservoir ecology and human serosurveys to estimate Lassa virus spillover in West Africa","volume":"17","author":"Basinski","year":"2021","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"10.1016\/j.ijid.2022.04.004_bib0011","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/15303660160025903","article-title":"Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations","volume":"1","author":"Bausch","year":"2001","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"12","key":"10.1016\/j.ijid.2022.04.004_bib0012","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/657315","article-title":"Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever","volume":"51","author":"Bausch","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2022.04.004_bib0013","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1128\/JCM.38.7.2670-2677.2000","article-title":"Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation","volume":"38","author":"Bausch","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0014","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1038\/s41598-020-65736-0","article-title":"Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak","volume":"10","author":"Boisen","year":"2020","journal-title":"Sci Rep"},{"issue":"15","key":"10.1016\/j.ijid.2022.04.004_bib0015","doi-asserted-by":"crossref","first-page":"6992","DOI":"10.1128\/JVI.74.15.6992-7004.2000","article-title":"Genetic diversity among Lassa virus strains","volume":"74","author":"Bowen","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2022.04.004_bib0016","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1743-422X-7-279","article-title":"Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever","volume":"7","author":"Branco","year":"2010","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.ijid.2022.04.004_bib0017","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.virol.2005.12.001","article-title":"A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins","volume":"345","author":"Bredenbeek","year":"2006","journal-title":"Virol J"},{"issue":"16","key":"10.1016\/j.ijid.2022.04.004_bib0018","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00093-18","article-title":"TIM-1 Mediates Dystroglycan-Independent Entry of Lassa Virus","volume":"92","author":"Brouillette","year":"2018","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.ijid.2022.04.004_bib0019","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4269\/ajtmh.1982.31.1038","article-title":"Pathology of Lassa virus infection in the rhesus monkey","volume":"31","author":"Callis","year":"1982","journal-title":"Am J Trop Med Hyg"},{"issue":"5396","key":"10.1016\/j.ijid.2022.04.004_bib0020","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1126\/science.282.5396.2079","article-title":"Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus","volume":"282","author":"Cao","year":"1998","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.ijid.2022.04.004_bib0021a","doi-asserted-by":"crossref","first-page":"12093","DOI":"10.1128\/JVI.00429-11","article-title":"Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages","volume":"85","author":"Carnec","year":"2011","journal-title":"Journal of virology"},{"issue":"12","key":"10.1016\/j.ijid.2022.04.004_bib0021b","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02230-17","article-title":"A vaccine platform against arenaviruses nased on a recombinant hyperattenuated Mopeia virus expressing heterologous glycoproteins","volume":"92","author":"Carnec","year":"2018","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0022","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/vaccines1030262","article-title":"Enhanced efficacy of a codon-optimized DNA vaccine encoding the glycoprotein precursor gene of Lassa virus in a guinea pig disease model when delivered by dermal electroporation","volume":"1","author":"Cashman","year":"2013","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"10.1016\/j.ijid.2022.04.004_bib0023","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1080\/21645515.2017.1356500","article-title":"A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever","volume":"13","author":"Cashman","year":"2017","journal-title":"Hum Vaccines Immunother"},{"issue":"14","key":"10.1016\/j.ijid.2022.04.004_bib0024","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1038\/sj.onc.1209239","article-title":"DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control","volume":"25","author":"Chang","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ijid.2022.04.004_bib0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.coviro.2019.07.003","article-title":"Antibody therapy for Lassa fever","volume":"37","author":"Cross","year":"2019","journal-title":"Current Opinion in Virology"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0026","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI131958","article-title":"Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death","volume":"130","author":"Cross","year":"2020","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0027","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jinf.2003.11.009","article-title":"The public health response to a case of Lassa fever in London in 2000","volume":"48","author":"Crowcroft","year":"2004","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0028","first-page":"197","article-title":"Lassa fever encephalopathy: clinical and laboratory findings","volume":"95","author":"Cummins","year":"1992","journal-title":"J Trop Med Hyg"},{"issue":"784","key":"10.1016\/j.ijid.2022.04.004_bib0029","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/pgmj.67.784.193","article-title":"Exchange transfusion of a patient with fulminant Lassa fever","volume":"67","author":"Cummins","year":"1991","journal-title":"Postgrad Med J"},{"issue":"16","key":"10.1016\/j.ijid.2022.04.004_bib0030","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/jama.1990.03450160063030","article-title":"Acute sensorineural deafness in Lassa fever","volume":"264","author":"Cummins","year":"1990","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0031","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/trstmh\/tru009","article-title":"Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone","volume":"108","author":"Dahmane","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.ijid.2022.04.004_bib0032","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/15303660160025912","article-title":"Lassa fever in Guinea: II. Distribution and prevalence of Lassa virus infection in small mammals","volume":"1","author":"Demby","year":"2001","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.ijid.2022.04.004_bib0033","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijid.2019.12.022","article-title":"Delayed-onset paraparesis in Lassa fever: A case report","volume":"92","author":"Duvignaud","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2022.04.004_bib0034","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1016\/S2214-109X(20)30518-0","article-title":"Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study","volume":"9","author":"Duvignaud","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2022.04.004_bib0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijid.2019.07.015","article-title":"Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis","volume":"87","author":"Eberhardt","year":"2019","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0036","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0035-9203(72)90268-4","article-title":"The pathology of Lassa fever","volume":"66","author":"Edington","year":"1972","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"21","key":"10.1016\/j.ijid.2022.04.004_bib0037","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00929-19","article-title":"Phylogeography of Lassa virus in Nigeria","volume":"93","author":"Ehichioya","year":"2019","journal-title":"Journal of virology"},{"issue":"12","key":"10.1016\/j.ijid.2022.04.004_bib0038","doi-asserted-by":"crossref","first-page":"ofz512","DOI":"10.1093\/ofid\/ofz512","article-title":"Sequelae of Lassa fever: Postviral cerebellar ataxia","volume":"6","author":"Ezeomah","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2022.04.004_bib0039","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01613-17","article-title":"Axl Can Serve as Entry Factor for Lassa Virus Depending on the Functional Glycosylation of Dystroglycan","volume":"92","author":"Fedeli","year":"2018","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/tera.1420170117","article-title":"Teratogenic effects of ribavirin on hamster and rat embryos","volume":"17","author":"Ferm","year":"1978","journal-title":"Teratology"},{"key":"10.1016\/j.ijid.2022.04.004_bib0041","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijid.2020.08.021","article-title":"Lassa fever induced hearing loss: The neglected disability of hemorrhagic fever","volume":"100","author":"Ficenec","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"9","key":"10.1016\/j.ijid.2022.04.004_bib0042","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/vbz.2013.1484","article-title":"Lassa serology in natural populations of rodents and horizontal transmission","volume":"14","author":"Fichet-Calvet","year":"2014","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0043","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41541-021-00291-x","article-title":"ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge","volume":"6","author":"Fischer","year":"2021","journal-title":"NPJ vaccines"},{"issue":"2","key":"10.1016\/j.ijid.2022.04.004_bib0044","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jmv.1890260204","article-title":"Hematologic dysfunction in Lassa fever","volume":"26","author":"Fisher-Hoch","year":"1988","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.ijid.2022.04.004_bib0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0166-3542(92)90073-E","article-title":"Unexpected adverse reactions during a clinical trial in rural West Africa","volume":"19","author":"Fisher-Hoch","year":"1992","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijid.2022.04.004_bib0046","first-page":"231","article-title":"Pathophysiology and treatment of Lassa fever","volume":"134","author":"Fisher-Hoch","year":"1987","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0047","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1073\/pnas.86.1.317","article-title":"Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene","volume":"86","author":"Fisher-Hoch","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7009","key":"10.1016\/j.ijid.2022.04.004_bib0048","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/bmj.311.7009.857","article-title":"Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice","volume":"311","author":"Fisher-Hoch","year":"1995","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000836","article-title":"T cell-dependence of Lassa fever pathogenesis","volume":"6","author":"Flatz","year":"2010","journal-title":"PLoS pathogens"},{"issue":"4","key":"10.1016\/j.ijid.2022.04.004_bib0050","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/v12040437","article-title":"Population structure of Lassa mammarenavirus in West Africa","volume":"12","author":"Forni","year":"2020","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.ijid.2022.04.004_bib0051","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4269\/ajtmh.1970.19.670","article-title":"Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings","volume":"19","author":"Frame","year":"1970","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0052","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0035-9203(84)90107-X","article-title":"The use of Lassa fever convalescent plasma in Nigeria","volume":"78","author":"Frame","year":"1984","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2022.04.004_bib0053","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijid.2021.02.046","article-title":"Raabe V, members of the Medical Countermeasures Working Group of the National Emerging Special Pathogens T, Education Center's Special Pathogens Research N. South American Hemorrhagic Fevers: A summary for clinicians","volume":"105","author":"Frank","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2022.04.004_bib0054","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"Geisbert","year":"2005","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.ijid.2022.04.004_bib0055","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.vaccine.2011.12.134","article-title":"Evaluation of Lassa virus vaccine immunogenicity in a CBA\/J-ML29 mouse model","volume":"30","author":"Goicochea","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.ijid.2022.04.004_bib0056","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3201\/eid2406.172097","article-title":"Absence of nosocomial transmission of imported Lassa fever during use of standard barrier nursing methods","volume":"24","author":"Grahn","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0057","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1086\/322033","article-title":"Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum","volume":"184","author":"Gunther","year":"2001","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.ijid.2022.04.004_bib0058","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3201\/eid1612.100994","article-title":"Ribavirin for Lassa fever postexposure prophylaxis","volume":"16","author":"Hadi","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2022.04.004_bib0059","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.coviro.2019.08.002","article-title":"Lassa fever diagnostics: Past, present, and future","volume":"37","author":"Happi","year":"2019","journal-title":"Curr Opin Virol"},{"issue":"6","key":"10.1016\/j.ijid.2022.04.004_bib0060","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1073\/pnas.1016404108","article-title":"Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3\u2032 to 5\u2032 exonuclease activity essential for immune suppression","volume":"108","author":"Hastie","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.ijid.2022.04.004_bib0061","doi-asserted-by":"crossref","first-page":"e44211","DOI":"10.1371\/journal.pone.0044211","article-title":"Structural basis for the dsRNA specificity of the Lassa virus NP exonuclease","volume":"7","author":"Hastie","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2022.04.004_bib0062","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1743-422X-8-205","article-title":"Pathogenesis of Lassa fever in cynomolgus macaques","volume":"8","author":"Hensley","year":"2011","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.ijid.2022.04.004_bib0063","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02869-18","article-title":"Dynamic Dystroglycan Complexes Mediate Cell Entry of Lassa Virus","volume":"10","author":"Herrador","year":"2019","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.ijid.2022.04.004_bib0064","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01146-20","article-title":"Inhibition of arenaviruses by combinations of orally available approved drugs","volume":"65","author":"Herring","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.ijid.2022.04.004_bib0065","doi-asserted-by":"crossref","DOI":"10.3390\/v12090907","article-title":"Effect of strain variations on Lassa virus Z protein-mediated human RIG-I inhibition","volume":"12","author":"Huang","year":"2020","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.ijid.2022.04.004_bib0066","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02185-18","article-title":"Arbidol and other low-molecular-weight drugs that inhibit Lassa and Ebola viruses","volume":"93","author":"Hulseberg","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2022.04.004_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104928","article-title":"Lassa virus antigen distribution and inflammation in the ear of infected strain 13\/N Guinea pigs","volume":"183","author":"Huynh","year":"2020","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.ijid.2022.04.004_bib0068","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00405-010-1370-4","article-title":"Early-onset sensorineural hearing loss in Lassa fever","volume":"268","author":"Ibekwe","year":"2011","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4","key":"10.1016\/j.ijid.2022.04.004_bib0069","doi-asserted-by":"crossref","DOI":"10.3390\/v12040386","article-title":"Inter-lineage variation of Lassa virus glycoprotein epitopes: A challenge to Lassa virus vaccine development","volume":"12","author":"Ibukun","year":"2020","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.ijid.2022.04.004_bib0070","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3201\/eid2506.181035","article-title":"Epidemiologic and clinical features of Lassa fever outbreak in Nigeria, January 1-May 6, 2018","volume":"25","author":"Ilori","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2022.04.004_bib0071","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jinf.2019.12.020","article-title":"Epidemiology and case-control study of Lassa fever outbreak in Nigeria from 2018 to 2019","volume":"80","author":"Ipadeola","year":"2020","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.ijid.2022.04.004_bib0072","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4103\/0300-1652.188362","article-title":"Postexposure prophylaxis for Lassa fever: Experience from a recent outbreak in Nigeria","volume":"57","author":"Isa","year":"2016","journal-title":"Niger Med J"},{"issue":"4","key":"10.1016\/j.ijid.2022.04.004_bib0073","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006337","article-title":"Mapping of the Lassa virus LAMP1 binding site reveals unique determinants not shared by other old world arenaviruses","volume":"13","author":"Israeli","year":"2017","journal-title":"PLoS Pathog"},{"issue":"6191","key":"10.1016\/j.ijid.2022.04.004_bib0074","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1126\/science.1252480","article-title":"Lassa virus entry requires a trigger-induced receptor switch","volume":"344","author":"Jae","year":"2014","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0075","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0035-9203(85)90388-8","article-title":"Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization","volume":"79","author":"Jahrling","year":"1985","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.ijid.2022.04.004_bib0076","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/infdis\/141.5.580","article-title":"Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin","volume":"141","author":"Jahrling","year":"1980","journal-title":"J Infect Dis"},{"issue":"8423","key":"10.1016\/j.ijid.2022.04.004_bib0077","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0140-6736(85)91029-3","article-title":"Early diagnosis of human Lassa fever by ELISA detection of antigen and antibody","volume":"1","author":"Jahrling","year":"1985","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ijid.2022.04.004_bib0078","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1128\/iai.44.2.528-533.1984","article-title":"Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain","volume":"44","author":"Jahrling","year":"1984","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0079","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/infdis\/149.3.420","article-title":"Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys","volume":"149","author":"Jahrling","year":"1984","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/004947506775598914","article-title":"A clinical guide to viral haemorrhagic fevers: Ebola, Marburg and Lassa","volume":"36","author":"Jeffs","year":"2006","journal-title":"Trop Doct"},{"issue":"9","key":"10.1016\/j.ijid.2022.04.004_bib0081","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1080\/21645515.2019.1616499","article-title":"Immunogenicity of a protective intradermal DNA vaccine against lassa virus in cynomolgus macaques","volume":"15","author":"Jiang","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0082","doi-asserted-by":"crossref","DOI":"10.3390\/v13030382","article-title":"Multivalent DNA vaccines as a strategy to combat multiple concurrent epidemics: Mosquito-borne and hemorrhagic fever viruses","volume":"13","author":"Jiang","year":"2021","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.ijid.2022.04.004_bib0083","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.vaccine.2010.11.079","article-title":"Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs","volume":"29","author":"Jiang","year":"2011","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.ijid.2022.04.004_bib0084","doi-asserted-by":"crossref","first-page":"16949","DOI":"10.1074\/jbc.M112.420521","article-title":"Structures of arenaviral nucleoproteins with triphosphate dsRNA reveal a unique mechanism of immune suppression","volume":"288","author":"Jiang","year":"2013","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0085","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/infdis\/155.3.456","article-title":"Clinical virology of Lassa fever in hospitalized patients","volume":"155","author":"Johnson","year":"1987","journal-title":"J Infect Dis"},{"issue":"6422","key":"10.1016\/j.ijid.2022.04.004_bib0086","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aau9343","article-title":"Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak","volume":"363","author":"Kafetzopoulou","year":"2019","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.ijid.2022.04.004_bib0087","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/infdis\/jiy123","article-title":"Use of a scalable replicon-particle vaccine to protect against lethal Lassa virus infection in the guinea pig model","volume":"217","author":"Kainulainen","year":"2018","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2022.04.004_bib0088","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/infdis\/jiz284","article-title":"Protection from lethal Lassa disease can be achieved both before and after virus exposure by administration of single-cycle replicating Lassa virus replicon particles","volume":"220","author":"Kainulainen","year":"2019","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2022.04.004_bib0089","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/infdis\/jiz284","article-title":"Protection From Lethal Lassa Disease Can Be Achieved Both Before and After Virus Exposure by Administration of Single-Cycle Replicating Lassa Virus Replicon Particles","volume":"220","author":"Kainulainen","year":"2019","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2022.04.004_bib0090","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/trstmh\/traa011","article-title":"Lassa fever in pregnancy: a systematic review and meta-analysis","volume":"114","author":"Kayem","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"10.1016\/j.ijid.2022.04.004_bib0091","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008589","article-title":"Systematic review and meta-analysis of the epidemiology of Lassa virus in humans, rodents and other mammals in sub-Saharan Africa","volume":"14","author":"Kenmoe","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"36","key":"10.1016\/j.ijid.2022.04.004_bib0092","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2019.07.023","article-title":"A vaccine based on recombinant modified Vaccinia Ankara containing the nucleoprotein from Lassa virus protects against disease progression in a guinea pig model","volume":"37","author":"Kennedy","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2022.04.004_bib0093","article-title":"Lassa virus genetics","author":"Klitting","year":"2020","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0094","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0041-008X(80)90252-5","article-title":"Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice","volume":"52","author":"Kochhar","year":"1980","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.ijid.2022.04.004_bib0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijid.2020.07.042","article-title":"Medical Countermeasures Working Group of the National Ebola T, Education Center's Special Pathogens Research N. Marburg virus disease: A summary for clinicians","volume":"99","author":"Kortepeter","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2022.04.004_bib0096","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1017\/ice.2019.349","article-title":"Serosurvey on healthcare personnel caring for patients with Ebola virus disease and Lassa virus in the United States","volume":"41","author":"Kraft","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.ijid.2022.04.004_bib0097","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/infdis\/jiab014","article-title":"Tetravalent Rabies-vectored filovirus and Lassa fever vaccine induces long-term immunity in nonhuman primates","volume":"224","author":"Kurup","year":"2021","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.ijid.2022.04.004_bib0098","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1128\/MCB.00560-10","article-title":"DDX3 regulates cell growth through translational control of cyclin E1","volume":"30","author":"Lai","year":"2010","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.ijid.2022.04.004_bib0099","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virol.2010.11.022","article-title":"Novel approaches in anti-arenaviral drug development","volume":"411","author":"Lee","year":"2011","journal-title":"Virology"},{"issue":"39","key":"10.1016\/j.ijid.2022.04.004_bib0100","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.39.17-00088","article-title":"Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016","volume":"22","author":"Lehmann","year":"2017","journal-title":"Euro Surveill"},{"issue":"12","key":"10.1016\/j.ijid.2022.04.004_bib0101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243766","article-title":"Ophthalmic manifestations and vision impairment in Lassa fever survivors","volume":"15","author":"Li","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijid.2022.04.004_bib0102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005418","article-title":"Acidic pH-induced conformations and LAMP1 binding of the Lassa virus glycoprotein spike","volume":"12","author":"Li","year":"2016","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008535","article-title":"Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin","volume":"17","author":"Lingas","year":"2021","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0104","doi-asserted-by":"crossref","first-page":"e3398","DOI":"10.1371\/journal.pntd.0003398","article-title":"Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission: the case of lassa fever","volume":"9","author":"Lo Iacono","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"10.1016\/j.ijid.2022.04.004_bib0105","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3390\/v4091651","article-title":"Uncovering viral protein-protein interactions and their role in arenavirus life cycle","volume":"4","author":"Loureiro","year":"2012","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0106","article-title":"Virus-host interactions involved in Lassa virus entry and genome replication","volume":"8","author":"Loureiro","year":"2019","journal-title":"Pathogens (Basel, Switzerland)"},{"issue":"7","key":"10.1016\/j.ijid.2022.04.004_bib0107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007125","article-title":"DDX3 suppresses type I interferons and favors viral replication during arenavirus infection","volume":"14","author":"Loureiro","year":"2018","journal-title":"PLoS pathogens"},{"issue":"41","key":"10.1016\/j.ijid.2022.04.004_bib0108","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1016\/j.vaccine.2008.07.057","article-title":"Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates","volume":"26","author":"Lukashevich","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0109","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jmv.1890400308","article-title":"Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen","volume":"40","author":"Lukashevich","year":"1993","journal-title":"J Med Virol"},{"issue":"22","key":"10.1016\/j.ijid.2022.04.004_bib0110","doi-asserted-by":"crossref","first-page":"13934","DOI":"10.1128\/JVI.79.22.13934-13942.2005","article-title":"A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses","volume":"79","author":"Lukashevich","year":"2005","journal-title":"J Virol"},{"issue":"3-4","key":"10.1016\/j.ijid.2022.04.004_bib0111","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01310811","article-title":"Ribonucleic acids of Machupo and Lassa viruses","volume":"79","author":"Lukashevich","year":"1984","journal-title":"Arch Virol"},{"key":"10.1016\/j.ijid.2022.04.004_bib0112","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104758","article-title":"Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates","volume":"177","author":"Madelain","year":"2020","journal-title":"Antiviral Res"},{"issue":"6","key":"10.1016\/j.ijid.2022.04.004_bib0113","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.4049\/jimmunol.170.6.2797","article-title":"Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses","volume":"170","author":"Mahanty","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2022.04.004_bib0114","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3389\/fmicb.2015.01037","article-title":"Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage","volume":"6","author":"Manning","year":"2015","journal-title":"Front Microbiol"},{"issue":"9","key":"10.1016\/j.ijid.2022.04.004_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009488","article-title":"The late endosome-resident lipid bis(monoacylglycero)phosphate is a cofactor for Lassa virus fusion","volume":"17","author":"Markosyan","year":"2021","journal-title":"PLoS Pathog"},{"issue":"45","key":"10.1016\/j.ijid.2022.04.004_bib0116","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1016\/j.vaccine.2019.09.030","article-title":"Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs","volume":"37","author":"Maruyama","year":"2019","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ijid.2022.04.004_bib0117","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3201\/eid2102.141649","article-title":"Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses","volume":"21","author":"Marzi","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.ijid.2022.04.004_bib0118","doi-asserted-by":"crossref","first-page":"e02006","DOI":"10.1128\/JVI.02006-19","article-title":"Lassa virus, but not highly pathogenic new world arenaviruses, restricts immunostimulatory double-stranded RNA accumulation during infection","volume":"94","author":"Mateer","year":"2020","journal-title":"J Virol"},{"issue":"512","key":"10.1016\/j.ijid.2022.04.004_bib0119","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw3163","article-title":"Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot","volume":"11","author":"Mateo","year":"2019","journal-title":"Sci Transl Med"},{"issue":"597","key":"10.1016\/j.ijid.2022.04.004_bib0120","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf6348","article-title":"A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains","volume":"13","author":"Mateo","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2022.04.004_bib0121","first-page":"69","article-title":"Epidemiology and control of Lassa fever","volume":"134","author":"McCormick","year":"1987","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0122","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/infdis\/155.3.445","article-title":"A case-control study of the clinical diagnosis and course of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0123","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever","volume":"314","author":"McCormick","year":"1986","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0124","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","article-title":"A prospective study of the epidemiology and ecology of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2022.04.004_bib0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.antiviral.2012.12.003","article-title":"Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever","volume":"97","author":"McLay","year":"2013","journal-title":"Antiviral Res"},{"issue":"9","key":"10.1016\/j.ijid.2022.04.004_bib0126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009788","article-title":"Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design","volume":"15","author":"Merson","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"10.1016\/j.ijid.2022.04.004_bib0127","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nm.4396","article-title":"Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever","volume":"23","author":"Mire","year":"2017","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ijid.2022.04.004_bib0128","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.4269\/ajtmh.1974.23.1140","article-title":"Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases","volume":"23","author":"Monath","year":"1974","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.ijid.2022.04.004_bib0129","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4269\/ajtmh.1987.36.408","article-title":"Pediatric Lassa fever: A review of 33 Liberian cases","volume":"36","author":"Monson","year":"1987","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41541-020-00219-x","article-title":"Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity","volume":"5","author":"Muller","year":"2020","journal-title":"NPJ vaccines"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0131","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/dmp.2014.151","article-title":"Favipiravir: A New Medication for the Ebola Virus Disease Pandemic","volume":"9","author":"Nagata","year":"2015","journal-title":"Disaster Med Public Health Prep"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0132","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/v4010083","article-title":"The curious case of arenavirus entry, and its inhibition","volume":"4","author":"Nunberg","year":"2012","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.ijid.2022.04.004_bib0133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005656","article-title":"Chimeric mice with competent hematopoietic immunity reproduce key features of severe Lassa fever","volume":"12","author":"Oestereich","year":"2016","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.ijid.2022.04.004_bib0134","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/infdis\/jiv522","article-title":"Efficacy of favipiravir alone and in combination with ribavirin in a lethal, immunocompetent mouse model of Lassa fever","volume":"213","author":"Oestereich","year":"2016","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2022.04.004_bib0135","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1473-3099(18)30121-X","article-title":"Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study","volume":"18","author":"Okokhere","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2022.04.004_bib0136","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000490374","article-title":"Acute Lassa virus encephalitis with Lassa virus in the cerebrospinal fluid but absent in the blood: A case report with a positive outcome","volume":"10","author":"Okokhere","year":"2018","journal-title":"Case Rep Neurol"},{"key":"10.1016\/j.ijid.2022.04.004_bib0137","doi-asserted-by":"crossref","first-page":"25280","DOI":"10.1038\/srep25280","article-title":"New Hosts of The Lassa Virus","volume":"6","author":"Olayemi","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0138","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s13071-018-2991-5","article-title":"Widespread arenavirus occurrence and seroprevalence in small mammals","volume":"11","author":"Olayemi","year":"2018","journal-title":"Nigeria. Parasit Vectors"},{"issue":"7","key":"10.1016\/j.ijid.2022.04.004_bib0139","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1128\/JCM.00998-12","article-title":"Rapid and specific detection of Lassa virus by reverse transcription-PCR coupled with oligonucleotide array hybridization","volume":"50","author":"Olschl\u00e4ger","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.ijid.2022.04.004_bib0140","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1128\/JCM.02351-09","article-title":"Improved detection of Lassa virus by reverse transcription-PCR targeting the 5\u2032 region of S RNA","volume":"48","author":"Olschlager","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0141","doi-asserted-by":"crossref","first-page":"e2637","DOI":"10.1371\/journal.pntd.0002637","article-title":"Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever","volume":"8","author":"Pannetier","year":"2014","journal-title":"PLoS neglected tropical diseases"},{"issue":"16","key":"10.1016\/j.ijid.2022.04.004_bib0142","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1128\/JVI.02120-10","article-title":"Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus","volume":"85","author":"Pannetier","year":"2011","journal-title":"Journal of virology"},{"issue":"21","key":"10.1016\/j.ijid.2022.04.004_bib0143","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01367-20","article-title":"Severe human Lassa gever is characterized by nonspecific T-cell activation and lymphocyte homing to inflamed tissues","volume":"94","author":"Port","year":"2020","journal-title":"J Virol"},{"issue":"6648","key":"10.1016\/j.ijid.2022.04.004_bib0144","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.297.6648.584","article-title":"A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy","volume":"297","author":"Price","year":"1988","journal-title":"BMJ"},{"issue":"7325","key":"10.1016\/j.ijid.2022.04.004_bib0145","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nature09605","article-title":"Cap binding and immune evasion revealed by Lassa nucleoprotein structure","volume":"468","author":"Qi","year":"2010","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ijid.2022.04.004_bib0146","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1128\/JCM.00170-17","article-title":"Laboratory diagnosis of Lassa fever","volume":"55","author":"Raabe","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.ijid.2022.04.004_bib0147","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/cid\/cix406","article-title":"Favipiravir and ribavirin treatment of epidemiologically linked cases of Lassa fever","volume":"65","author":"Raabe","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2022.04.004_bib0148","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1038\/s41467-021-25910-y","article-title":"Geographical drivers and climate-linked dynamics of Lassa fever in Nigeria","volume":"12","author":"Redding","year":"2021","journal-title":"Nat Commun"},{"issue":"7426","key":"10.1016\/j.ijid.2022.04.004_bib0149","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","article-title":"Lassa fever: Epidemiology, clinical features, and social consequences","volume":"327","author":"Richmond","year":"2003","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.ijid.2022.04.004_bib0150","doi-asserted-by":"crossref","first-page":"8185","DOI":"10.1128\/JVI.07240-11","article-title":"Arenavirus nucleoproteins prevent activation of nuclear factor kappa B","volume":"86","author":"Rodrigo","year":"2012","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.ijid.2022.04.004_bib0151","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3201\/eid2409.180233","article-title":"Use of Favipiravir to Treat Lassa Virus Infection in Macaques","volume":"24","author":"Rosenke","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"23","key":"10.1016\/j.ijid.2022.04.004_bib0152","doi-asserted-by":"crossref","first-page":"13811","DOI":"10.1128\/JVI.01908-14","article-title":"The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses","volume":"88","author":"Russier","year":"2014","journal-title":"Journal of virology"},{"issue":"4","key":"10.1016\/j.ijid.2022.04.004_bib0153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003736","article-title":"A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses","volume":"9","author":"Safronetz","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2022.04.004_bib0154","doi-asserted-by":"crossref","first-page":"14775","DOI":"10.1038\/srep14775","article-title":"The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset","volume":"5","author":"Safronetz","year":"2015","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.ijid.2022.04.004_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009522","article-title":"Time to reconsider the role of ribavirin in Lassa fever","volume":"15","author":"Salam","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0156","first-page":"133","article-title":"A Single Dose of Modified Vaccinia Ankara Expressing Lassa Virus-like Particles Protects Mice from Lethal Intra-cerebral Virus Challenge","volume":"8","author":"Salvato","year":"2019","journal-title":"Pathogens (Basel, Switzerland)"},{"issue":"2","key":"10.1016\/j.ijid.2022.04.004_bib0157","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4269\/ajtmh.20-0773","article-title":"Lassa fever among children in Eastern province, Sierra Leone: A 7-year retrospective analysis (2012-2018)","volume":"104","author":"Samuels","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"10.1016\/j.ijid.2022.04.004_bib0158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007430","article-title":"Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells","volume":"14","author":"Schaeffer","year":"2018","journal-title":"PLoS pathogens"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0159","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2021.152076","article-title":"Immunological screening of Lassa Virus among health workers and contacts of patients of Lassa fever in Ondo State","volume":"226","author":"Shaibu","year":"2021","journal-title":"Immunobiology"},{"issue":"15","key":"10.1016\/j.ijid.2022.04.004_bib0160","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1128\/JVI.00597-16","article-title":"Small-molecule fusion inhibitors bind the pH-sensing stable signal peptide-GP2 subunit interface of the Lassa virus envelope glycoprotein","volume":"90","author":"Shankar","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2022.04.004_bib0161","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fpubh.2018.00232","article-title":"Lassa fever 2016 outbreak in Plateau State, Nigeria-The changing epidemiology and clinical presentation","volume":"6","author":"Shehu","year":"2018","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijid.2022.04.004_bib0162","article-title":"Pathology and pathogenesis of Lassa fever: Novel immunohistochemical findings in fatal cases and clinico-pathologic correlation","author":"Shieh","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2022.04.004_bib0163","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1128\/JVI.06451-11","article-title":"Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry","volume":"86","author":"Shimojima","year":"2012","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.ijid.2022.04.004_bib0164","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1128\/JVI.76.10.5140-5146.2002","article-title":"New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor","volume":"76","author":"Spiropoulou","year":"2002","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.ijid.2022.04.004_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009966","article-title":"Differential pathogenesis of closely related 2018 Nigerian outbreak clade III Lassa virus isolates","volume":"17","author":"Stein","year":"2021","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.ijid.2022.04.004_bib0166","doi-asserted-by":"crossref","DOI":"10.3390\/v13091763","article-title":"CP100356 hydrochloride, a P-glycoprotein inhibitor, inhibits Lassa virus entry: implication of a candidate pan-mammarenavirus entry inhibitor","volume":"13","author":"Takenaga","year":"2021","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.ijid.2022.04.004_bib0167","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4269\/ajtmh.1988.38.407","article-title":"Viral hemorrhagic fever antibodies in Nigerian populations","volume":"38","author":"Tomori","year":"1988","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"10.1016\/j.ijid.2022.04.004_bib0168","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1128\/JVI.80.8.4191-4195.2006","article-title":"Cellular factors required for Lassa virus budding","volume":"80","author":"Urata","year":"2006","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.ijid.2022.04.004_bib0169","first-page":"107","article-title":"Lassa Fever-associated Stigmatization among Staff and Students of the University of Benin, Nigeria","volume":"9","author":"Usifoh","year":"2019","journal-title":"J Epidemiol Glob Health"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0170","first-page":"349","article-title":"Pathologic and virologic study of fatal Lassa fever in man","volume":"107","author":"Walker","year":"1982","journal-title":"Am J Pathol"},{"issue":"4-6","key":"10.1016\/j.ijid.2022.04.004_bib0171","first-page":"523","article-title":"Comparative pathology of Lassa virus infection in monkeys, guinea-pigs, and Mastomys natalensis","volume":"52","author":"Walker","year":"1975","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0172","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab029","article-title":"The reproductive number of Lassa fever: A systematic review","volume":"28","author":"Wang","year":"2021","journal-title":"J Travel Med"},{"issue":"5","key":"10.1016\/j.ijid.2022.04.004_bib0173","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.vaccine.2017.12.046","article-title":"Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins","volume":"36","author":"Wang","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0174","doi-asserted-by":"crossref","DOI":"10.3390\/v13030484","article-title":"Construction and immunological evaluation of an adenoviral vector-based vaccine candidate for Lassa fever","volume":"13","author":"Wang","year":"2021","journal-title":"Viruses"},{"issue":"16","key":"10.1016\/j.ijid.2022.04.004_bib0175","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00954-18","article-title":"Screening and identification of Lassa virus entry inhibitors from an FDA-approved drug library","volume":"92","author":"Wang","year":"2018","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.ijid.2022.04.004_bib0176","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jinf.2020.01.021","article-title":"High heart rate at admission as a predictive factor of mortality in hospitalized patients with Lassa fever: An observational cohort study in Sierra Leone","volume":"80","author":"Wauquier","year":"2020","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.ijid.2022.04.004_bib0177","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3201\/eid2403.171905","article-title":"New lineage of Lassa virus, Togo, 2016","volume":"24","author":"Whitmer","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"4-6","key":"10.1016\/j.ijid.2022.04.004_bib0178","first-page":"535","article-title":"The pathology of human Lassa fever","volume":"52","author":"Winn","year":"1975","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.ijid.2022.04.004_bib0179","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaa035","article-title":"Fifty years of imported Lassa fever: a systematic review of primary and secondary cases","volume":"27","author":"Wolf","year":"2020","journal-title":"J Travel Med"},{"key":"10.1016\/j.ijid.2022.04.004_bib0180","article-title":"Detection of Lassa virus in wild rodent feces: Implications for Lassa fever burden within households in the endemic region of Faranah","volume":"13","author":"Wood","year":"2021","journal-title":"Guinea. One Health"},{"key":"10.1016\/j.ijid.2022.04.004_bib0181","series-title":"2017 Annual review of diseases prioritized under the research and development blueprint","year":"2017"},{"key":"10.1016\/j.ijid.2022.04.004_bib0182","series-title":"Lassa fever","year":"2017"},{"key":"10.1016\/j.ijid.2022.04.004_bib0183","article-title":"Lassa fever \u2013 United Kingdom of Great Britain and Northern Ireland","year":"2022","journal-title":"Disease Outbreak News"},{"issue":"5","key":"10.1016\/j.ijid.2022.04.004_bib0184","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1128\/JVI.03349-14","article-title":"The Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit RIG-I-like receptor-dependent interferon production","volume":"89","author":"Xing","year":"2015","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.ijid.2022.04.004_bib0185","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/s41564-021-00916-w","article-title":"Cryo-EM structures of Lassa and Machupo virus polymerases complexed with cognate regulatory Z proteins identify targets for antivirals","volume":"6","author":"Xu","year":"2021","journal-title":"Nat Microbiol"},{"issue":"10","key":"10.1016\/j.ijid.2022.04.004_bib0186","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3201\/eid2510.180523","article-title":"Lassa Virus in Pygmy Mice, Benin, 2016-2017","volume":"25","author":"Yadouleton","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2022.04.004_bib0187","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.713372","article-title":"Simultaneous detection of Ebola virus and pathogens associated with hemorrhagic fever by an oligonucleotide microarray","volume":"12","author":"Yao","year":"2021","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.ijid.2022.04.004_bib0188","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1128\/JVI.06284-11","article-title":"Functional interferon system is required for clearance of lassa virus","volume":"86","author":"Yun","year":"2012","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.ijid.2022.04.004_bib0189","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1128\/JVI.02948-15","article-title":"Animal model of sensorineural hearing loss associated with Lassa virus infection","volume":"90","author":"Yun","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2022.04.004_bib0190","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1743-422X-10-52","article-title":"An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity","volume":"10","author":"Zapata","year":"2013","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.ijid.2022.04.004_bib0191","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s13238-018-0604-x","article-title":"Structure-activity relationship optimization for lassa virus fusion inhibitors targeting the transmembrane domain of GP2","volume":"10","author":"Zhang","year":"2019","journal-title":"Protein Cell"},{"key":"10.1016\/j.ijid.2022.04.004_bib0192","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104701","article-title":"The antifungal isavuconazole inhibits the entry of lassa virus by targeting the stable signal peptide-GP2 subunit interface of lassa virus glycoprotein","volume":"174","author":"Zhang","year":"2020","journal-title":"Antiviral Res"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222002053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222002053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:08:34Z","timestamp":1761120514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971222002053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":193,"alternative-id":["S1201971222002053"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2022.04.004","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lassa Virus Infection: a Summary for Clinicians","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2022.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}